Loading insider details...
Latest Form 4 (Nov 16, 2026): Exercise/Conversion of 50,000 ABCL shares, $16.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | AbCellera Biologics Inc. (ABCL) | Exercise/Conversion | 50,000 | $16.1K |
| Nov 13, 2026 | AbCellera Biologics Inc. (ABCL) | Purchase | 8,600 | $97.4K |
| Aug 14, 2026 | AbCellera Biologics Inc. (ABCL) | Purchase | 37,200 | $383.9K |
| Jun 3, 2026 | AbCellera Biologics Inc. (ABCL) | Exercise/Conversion | 250,000 | $47.5K |
| Feb 27, 2026 | AbCellera Biologics Inc. (ABCL) | Purchase | 42,600 | $145.7K |
| Jan 5, 2026 | AbCellera Biologics Inc. (ABCL) | Grant/Award | 808,898 | n/a |
| Jan 3, 2025 | AbCellera Biologics Inc. (ABCL) | Grant/Award | 1,352,054 | n/a |
| Jan 16, 2024 | AbCellera Biologics Inc. (ABCL) | Grant/Award | 770,416 | n/a |
| May 26, 2023 | AbCellera Biologics Inc. (ABCL) | Purchase | 14,500 | $99.3K |
| Dec 22, 2022 | AbCellera Biologics Inc. (ABCL) | Exercise/Conversion | 50,000 | $9.5K |